Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alicia Macias-Valcayo"'
Autor:
Alicia Macias-Valcayo, John-Jairo Aguilera-Correa, Antonio Broncano, Raul Parron, Alvaro Auñon, Joaquin Garcia-Cañete, Antonio Blanco, Jaime Esteban
Publikováno v:
Microbiology Spectrum. 10
This study is the first one to analyze a high number of isolates of Gram-negative bacilli that are the cause of prosthetic joint infection. The analysis includes biofilm development and antimicrobial susceptibility testing of both planktonic and sess
Autor:
Alicia, Macias-Valcayo, John-Jairo, Aguilera-Correa, Antonio, Broncano, Raul, Parron, Alvaro, Auñon, Joaquin, Garcia-Cañete, Antonio, Blanco, Jaime, Esteban
Publikováno v:
Microbiology spectrum. 10(4)
Prosthetic joint infections (PJIs) are typically caused by microorganisms that grow in biofilms. Traditional antimicrobial susceptibility tests are based on the study of planktonic bacteria that might lead to missing the biofilm behavior and to a tre
Autor:
María Jesús Rodríguez Nieto, Marta Lopez de las Heras, Silvia Calpena Martínez, Sarah Heili-Frades, Irene Carrillo Acosta, Aws Waleed Mohammed Al-Hayani, Laura Prieto-Pérez, Alba Naya, Javier Martinez, Miguel Ángel Piris Pinilla, Alicia Macias Valcayo, Marcel Jose Rodriguez Guzman, Ricardo Fernández Roblas, Miguel de Górgolas Hernández-Mora, Felipe Villar Álvarez, Alfonso Cabello Úbeda, José Fortes Alen, Pilar Carballosa, B. Alvarez, Fredeswinda Romero Bueno, Germán Peces-Barba Romero, Olga Sánchez Pernaute, Itziar Fernández Ormaechea, Marina Castellanos Gonzalez, Farah Ezzine, Antonio Broncano Lavado, Marta Martin Garcia, Ana Cordero Guijarro
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 102, Iss, Pp 303-309 (2021)
International Journal of Infectious Diseases, Vol 102, Iss, Pp 303-309 (2021)
Graphical abstract
Highlights • The survival rate is high (94% vs 72%) if tocilizumab is administered with a FiO2 ≤ 0.5%. • There are very limited side effects and secondary infections. • A significant decrease in the median serum ferrit
Highlights • The survival rate is high (94% vs 72%) if tocilizumab is administered with a FiO2 ≤ 0.5%. • There are very limited side effects and secondary infections. • A significant decrease in the median serum ferrit
Autor:
Corrin Graue, Bryan H Schmitt, Amy Waggoner, Frederic Laurent, Lelia Abad, Thomas Bauer, Irving Mazariegos, Joan-Miquel Balada-Llasat, Jarid Horn, Donna Wolk, Alexa Jefferis, Mirjam Hermans, Irma Verhoofstad, Susan Butler-Wu, Minette Umali-Wilcox, Caitlin N Murphy, Barbara J Cabrera, Jaime Esteban, Alicia Macias-Valcayo, David Craft, Benjamin von Bredow, Amy Leber, Kathy Everhart, Jennifer Dien Bard, Javier Mestas, Judy Daly, Rebecca Barr, Bart Kensinger, Benedicte Pons, Corinne Jay
Publikováno v:
Open Forum Infectious Diseases
Background Bone and Joint Infections (BJIs) present with non-specific symptoms that may include pain, swelling, and fever and are associated with high morbidity and significant risk of mortality. BJIs can be caused by a variety of bacteria and fungi,